Tactile Medical to Participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference

Printer-friendly versionPrinter-friendly versionSend by emailSend by email
Friday, December 8th, 2017

MINNEAPOLIS, Dec. 07, 2017 (GLOBE NEWSWIRE/KOREA IT TIMES) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company focused on developing medical devices for the treatment of chronic diseases at home, today announced that management will participate in the Guggenheim Securities 5th Annual Boston Healthcare Conference at the InterContinental Hotel in Boston, MA. Management will attend on Wednesday, December 13 and participate in investor meetings. There will be no formal presentation to investors.

About Tactile Medical

Tactile Medical is a leader in developing and marketing at-home therapy devices that treat chronic swelling conditions such as lymphedema and chronic venous insufficiency. Our mission is to help people suffering from chronic diseases live better and care for themselves at home. Our unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinical staff. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.

CONTACT: Investor Inquiries:
Mike Piccinino, CFA
Managing Director
Westwicke Partners
443-213-0500
investorrelations@tactilemedical.com

Comments

Hanwha onsure

samsung fire

new energy